Protective effect of Ghrelin on left ventricular remodeling in spontaneously hypertensive rats is associated with the peroxisome proliferator-activated receptor gamma-dependent pathway

Chinese Medical Journal

Volumn 121, Issue 22, 2008, Pages 2299-2304

  Li, Zhao ^a   Zhu, Xiao Ying ^a   Li, Meng ^a   Bai, Ying Long ^a   Hu, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Collagen; Ghrelin; Hypertension; Left ventricular remodeling; Peroxisome proliferator activated receptor gamma

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; GHRELIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART PROTECTION; HEART VENTRICLE REMODELING; HEMODYNAMIC MONITORING; HISTOPATHOLOGY; HYPERTENSION; IMAGE ANALYSIS; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 62749184886     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811020-00016     Document Type: Article

References (20)

1. De Vriese C, Delporte C. Ghrelin: a new peptide regulating growth hormone release and food intake. Int J biochem Cell Biol 2008; 40: 1420-1424.
2. Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 2008; 294: H426-H432.
3. Xu Z, Wu W, Zhang X, Liu G. Endogenous ghrelin increases in adriamycin-induced heart failure rats. J Endocrinol Invest 2007; 30: 117-125.
4. Henderson BC, Sen U, Reynolds C, Moshal KS, Ovechkin A, Tyagi N, et al. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J biol Sci 2007; 3: 385-392.
5. Díez J. Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 2007; 9: 546-550.
6. Duan SZ, Ivashchenko CY, Usher MG, Mortensen RM. PPAR-gamma in the cardiovascular system. PPAR Res 2008; 2008: 745804.
7. Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003; 144: 754-759.
8. Takeda R, Nishimatsu H, Suzuki E, Satonaka H, Nagata D, Oba S, et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 113-121.
9. Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, Peng XZ, et al. GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 2005; 289: H1643-H1651.
10. D'Ascia C, Cittadini A, Monti MG, Riccio G, Saccà L. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. Eur Heart J 2006; 27: 201-206.
11. Bu PL, Zhao XQ, Wang LL, Zhao YX, Li CB, Zhang Y. Tong-xin-luo capsule inhibits left ventricular remodeling in spontaneously hypertensive rats by enhancing PPAR-gamma expression and suppressing NF-kappa B activity. Chin Med J 2008; 121: 147-154.
12. Lim S. Recent update in the management of hypertension. Acta Med Indones 2007; 39: 186-191.
13. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435.
14. Alibin CP, Kopilas MA, Anderson HD. Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma. J Biol Chem 2008; 283: 10707-10715.
15. Ernsberger P, Johnson JL, Rosenthal T, Mirelman D, Koletsky RJ. Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens 2007; 20: 866-874.
16. Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, et al. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. Mol Endocrinol 2006; 20: 3165-3178.
17. Nagaya N, Kangawa K. Therapeutic potential of ghrelin in the treatment of heart failure. Drugs 2006; 66: 439-448.
18. Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, et al. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT study. J Am Coll Cardiol 2007; 49: 290-297.
19. Kang MS, Hirai S, Goto T, Kuroyanagi K, Lee JY, Uemura T, et al. Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation. Biochem Biophys Res Commun 2008; 369: 333-338.
20. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008; 7: 1020-1035.